{"prompt": "Please generate a procedure note for Dr. Dr. Gupta. Patient is 69 male with a 0.9 cm RLL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Necrotic debris. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 32yo M. Target RUL Posterior Segment (1.5cm). ROSE showed Atypical cells present. EBUS staging neg. Attending Dr. Gupta.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RLL Superior Segment, 3.1 cm\nROSE: Granulomatous Inflammation\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 3.1 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RUL Posterior Segment, 1.5 cm\nROSE: Adenocarcinoma\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx D38.1. Patient 45 F. Site: RLL RB6. Findings: Adenocarcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 77yo M. Target LLL Anteromedial Segment (1.2cm). ROSE showed Granulomatous Inflammation. EBUS staging neg. Attending Dr. Alvarez.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 77yo M. Target LLL Superior Segment (0.9cm). ROSE showed Adenocarcinoma. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx R91.8. Patient 52 M. Site: RUL RB1. Findings: Non-small cell lung carcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 64\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RLL Posterior Basal Segment, 1.2 cm\nROSE: Atypical cells present\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Anteromedial Segment, 0.9 cm\nROSE: Squamous Cell Carcinoma\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Ingraham. Patient is 58 female with a 2.0 cm LLL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Squamous Cell Carcinoma. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 58\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LUL Anterior Segment, 1.2 cm\nROSE: Granulomatous Inflammation\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Rossi. Patient is 52 female with a 3.8 cm RUL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Squamous Cell Carcinoma. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 52yo M. Target LLL Anteromedial Segment (2.5cm). ROSE showed Adenocarcinoma. EBUS staging neg. Attending Dr. Gupta.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "81F LUL nodule 2.5cm. robotic bronch + ebus. rose: Granulomatous Inflammation. ref by Dr. Doe. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 32\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LUL Anterior Segment, 2.5 cm\nROSE: Necrotic debris\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Ingraham. Patient is 32 female with a 2.5 cm RUL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Atypical cells present. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 69\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LUL Anterior Segment, 0.9 cm\nROSE: Fungus\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 64\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Posterior Basal Segment, 2.0 cm\nROSE: Non-small cell lung carcinoma\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the LLL (LB10).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx R91.1. Patient 77 M. Site: LLL Lb7/8. Findings: Granulomatous Inflammation.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RLL Posterior Basal Segment, 1.5 cm\nROSE: Atypical cells present\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx R91.8. Patient 45 M. Site: RLL RB10. Findings: Atypical cells present.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Anteromedial Segment, 0.9 cm\nROSE: Fungus\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 69yo M. Target LUL Apicoposterior Segment (2.5cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Rossi.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apicoposterior Segment of the LUL (LB1+2).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx R91.1. Patient 81 F. Site: LLL Lb7/8. Findings: Atypical cells present.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "58F RUL nodule 2.5cm. robotic bronch + ebus. rose: Squamous Cell Carcinoma. ref by Dr. Chen. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx R91.1. Patient 69 F. Site: RUL RB1. Findings: Granulomatous Inflammation.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx D38.1. Patient 52 M. Site: LUL LB3. Findings: Squamous Cell Carcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Anteromedial Segment, 1.5 cm\nROSE: Fungus\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 64yo M. Target LLL Superior Segment (0.9cm). ROSE showed Atypical cells present. EBUS staging neg. Attending Dr. Alvarez.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 73yo M. Target RLL Posterior Basal Segment (2.0cm). ROSE showed Atypical cells present. EBUS staging neg. Attending Dr. Thompson.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 73-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n73-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx D38.1. Patient 32 F. Site: LLL Lb7/8. Findings: Non-small cell lung carcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 3.1 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Ingraham. Patient is 73 female with a 2.5 cm RUL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Non-small cell lung carcinoma. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 73-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n73-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "64F RUL nodule 2.0cm. robotic bronch + ebus. rose: Fungus. ref by Dr. Patel. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 32\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RUL Apical Segment, 0.9 cm\nROSE: Fungus\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 81yo M. Target LLL Anteromedial Segment (0.9cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "69F LUL nodule 1.5cm. robotic bronch + ebus. rose: Squamous Cell Carcinoma. ref by Dr. Bowers. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apicoposterior Segment of the LUL (LB1+2).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 77\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RUL Posterior Segment, 2.0 cm\nROSE: Adenocarcinoma\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 32\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RLL Superior Segment, 3.1 cm\nROSE: Necrotic debris\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 3.1 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 64yo M. Target RLL Superior Segment (0.9cm). ROSE showed Non-small cell lung carcinoma. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "77F RLL nodule 1.5cm. robotic bronch + ebus. rose: Necrotic debris. ref by Dr. Jones. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Thompson. Patient is 77 female with a 3.1 cm LUL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Adenocarcinoma. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apicoposterior Segment of the LUL (LB1+2).\nThe target lesion was approximately 3.1 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Ingraham. Patient is 69 female with a 2.0 cm LUL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Atypical cells present. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx C34.90. Patient 52 F. Site: RLL RB6. Findings: Fungus.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 58yo M. Target RLL Superior Segment (2.0cm). ROSE showed Atypical cells present. EBUS staging neg. Attending Dr. Rossi.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx C34.90. Patient 81 M. Site: LUL LB3. Findings: Fungus.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anterior Segment of the LUL (LB3).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 32\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Posterior Basal Segment, 0.9 cm\nROSE: Atypical cells present\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the LLL (LB10).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 81yo F. Target LUL Apicoposterior Segment (0.9cm). ROSE showed Squamous Cell Carcinoma. EBUS staging neg. Attending Dr. Alvarez.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apicoposterior Segment of the LUL (LB1+2).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 77yo F. Target LLL Posterior Basal Segment (1.5cm). ROSE showed Non-small cell lung carcinoma. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the LLL (LB10).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "45F RUL nodule 2.0cm. robotic bronch + ebus. rose: Fungus. ref by Dr. Bowers. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx C34.90. Patient 45 F. Site: LLL Lb7/8. Findings: Necrotic debris.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx D38.1. Patient 77 M. Site: RUL RB1. Findings: Adenocarcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Rossi. Patient is 73 female with a 2.5 cm RLL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Adenocarcinoma. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 73-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n73-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 45yo F. Target LUL Apicoposterior Segment (3.8cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Alvarez.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apicoposterior Segment of the LUL (LB1+2).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 32\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RUL Posterior Segment, 1.2 cm\nROSE: Granulomatous Inflammation\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx R91.1. Patient 45 F. Site: RLL RB6. Findings: Atypical cells present.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 64yo F. Target LLL Anteromedial Segment (3.1cm). ROSE showed Squamous Cell Carcinoma. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Squamous Cell Carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Anteromedial Segment of the LLL (Lb7/8).\nThe target lesion was approximately 3.1 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Squamous Cell Carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Squamous Cell Carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 81yo M. Target LLL Superior Segment (2.0cm). ROSE showed Fungus. EBUS staging neg. Attending Dr. Rossi.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx D38.1. Patient 45 F. Site: RUL RB2. Findings: Fungus.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Rossi. Patient is 52 male with a 3.1 cm LLL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Necrotic debris. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 3.1 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 45yo M. Target RUL Posterior Segment (3.8cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Alvarez.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 45-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n45-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx C34.90. Patient 73 F. Site: LLL LB6. Findings: Non-small cell lung carcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 73-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n73-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "58F LUL nodule 2.5cm. robotic bronch + ebus. rose: Granulomatous Inflammation. ref by Dr. Bowers. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LUL target \nTransbronchial cryobiopsy of LUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apicoposterior Segment of the LUL (LB1+2).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLUL transbronchial brush (1 sample) \u2014 Cytology \nLUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 32yo M. Target RLL Posterior Basal Segment (0.9cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Gupta.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "58F LLL nodule 1.5cm. robotic bronch + ebus. rose: Necrotic debris. ref by Dr. Chen. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx C34.90. Patient 58 F. Site: RLL RB6. Findings: Fungus.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 77\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RLL Superior Segment, 1.5 cm\nROSE: Necrotic debris\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "69F LLL nodule 1.2cm. robotic bronch + ebus. rose: Granulomatous Inflammation. ref by Dr. Miller. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the LLL (LB10).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Thompson. Patient is 64 male with a 2.5 cm LLL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Adenocarcinoma. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the LLL (LB6).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "81F RUL nodule 2.5cm. robotic bronch + ebus. rose: Atypical cells present. ref by Dr. Bowers. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Atypical cells present \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Atypical cells present.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Atypical cells present.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 69\nGender: male\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Posterior Basal Segment, 2.0 cm\nROSE: Fungus\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Patel\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the LLL (LB10).\nThe target lesion was approximately 2.0 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 52\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RUL Posterior Segment, 1.2 cm\nROSE: Fungus\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\nThe patient is a 52-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Fungus \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Fungus.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n52-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Fungus.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 32yo F. Target RLL Posterior Basal Segment (3.8cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 32-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nD38.1 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 3.8 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n32-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 81\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: LLL Posterior Basal Segment, 2.5 cm\nROSE: Non-small cell lung carcinoma\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 81-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of LLL target \nTransbronchial cryobiopsy of LLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Alvarez\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the LLL (LB10).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nLLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the LLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nLLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nLLL transbronchial brush (1 sample) \u2014 Cytology \nLLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nLLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n81-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Code for Ion Bronchoscopy + EBUS + Fiducial. Dx C34.90. Patient 69 M. Site: RLL RB10. Findings: Adenocarcinoma.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Doe\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Adenocarcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Adenocarcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Adenocarcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Gupta. Patient is 64 female with a 1.5 cm RLL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Granulomatous Inflammation. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 64-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Basal Segment of the RLL (RB10).\nThe target lesion was approximately 1.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 1 (soft) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 1 (soft) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n64-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Operative note: Ion bronch. 73yo F. Target RLL Superior Segment (0.9cm). ROSE showed Necrotic debris. EBUS staging neg. Attending Dr. Ingraham.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Weiss\n\nINDICATION FOR OPERATION\nThe patient is a 73-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Necrotic debris \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RLL target \nTransbronchial cryobiopsy of RLL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Ingraham\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Superior Segment of the RLL (RB6).\nThe target lesion was approximately 0.9 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRLL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RLL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Necrotic debris.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRLL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRLL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRLL transbronchial brush (1 sample) \u2014 Cytology \nRLL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRLL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n73-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Necrotic debris.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "77F RUL nodule 2.5cm. robotic bronch + ebus. rose: Granulomatous Inflammation. ref by Dr. Jones. fiducial placed.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Jones\n\nINDICATION FOR OPERATION\nThe patient is a 77-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Rossi\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 2.5 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n77-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Please generate a procedure note for Dr. Dr. Gupta. Patient is 69 male with a 1.2 cm RUL nodule. We used Ion, rEBUS, and Cone Beam CT. ROSE was Granulomatous Inflammation. No EBUS nodes sampled.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 69-year-old male who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Solitary Lung Nodule \n\nROSE from Ion procedure noted Granulomatous Inflammation \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Gupta\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Apical Segment of the RUL (RB1).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Granulomatous Inflammation.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 2 (mixed soft/stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 2 (mixed soft/stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n69-year-old male with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Granulomatous Inflammation.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
{"prompt": "Patient Age: 58\nGender: female\nProcedure: Robotic Bronchoscopy (Ion)\nTarget: RUL Posterior Segment, 1.2 cm\nROSE: Non-small cell lung carcinoma\nComplications: None", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Miller\n\nINDICATION FOR OPERATION\nThe patient is a 58-year-old female who presents with a lung nodule.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\n\nCONSENT\nObtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nThe patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Solitary Lung Nodule \n\nROSE from Ion procedure noted Non-small cell lung carcinoma \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) \nTherapeutic aspiration (initial and subsequent) \nRadial EBUS (rEBUS) lesion verification \nCone-beam CT (Cios Spin) with 3D reconstruction \nTransbronchial needle aspiration (TBNA) of RUL target \nTransbronchial cryobiopsy of RUL target \nTransbronchial brushing \nBronchoalveolar lavage (BAL) \nFiducial marker placement \nEndobronchial Ultrasound (EBUS) of mediastinal/hilar lymph nodes (staging) without biopsy \n\nATTENDING\nDr. Thompson\n\nANESTHESIA\nGeneral Anesthesia \n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer present throughout the entire procedure.\n\nINSTRUMENTATION\nLinear EBUS, Radial EBUS, Ion Robotic Bronchoscope, Disposable Bronchoscope.\n\nESTIMATED BLOOD LOSS\nMinimum \n\nCOMPLICATIONS\nNone \n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location.\nInitial Airway Inspection: Normal appearing airway anatomy and mucosa bilaterally to the segmental level.\nSuccessful therapeutic aspiration was performed to clean out the Trachea, Right Mainstem, Bronchus Intermedius, Left Mainstem, Carina, and bilateral lobar carinas from mucus.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Nodule: A CT chest scan was utilized on a separate planning station to generate a 3D rendering of the pathway to the target.\nThe navigational plan was reviewed, verified, and loaded into the robotic platform.\nRobotic navigation was performed with the Ion platform using partial registration.\n\nTarget: The Ion robotic catheter was used to engage the Posterior Segment of the RUL (RB2).\nThe target lesion was approximately 1.2 cm in diameter.\n\nNavigation: Under navigational guidance, the catheter was advanced to 1.0 cm away from the planned target.\nrEBUS Verification: Radial EBUS was performed, confirming the nodule location was eccentric.\nFeatures noted included a continuous margin and absence of a linear-discrete air bronchogram.\n\nCone-Beam CT (Cios Spin): A low-dose spin was performed to acquire CT imaging.\n3D reconstructions were performed and interpreted on an independent workstation.\nAdjustment: Using the newly acquired nodule location from the Cios Spin system, the Ion robotic system was adjusted to the new targeted location.\n\nRUL Target Sampling:\nTBNA: Transbronchial needle aspiration was performed with a 21G needle through the extended working channel.\nTotal 4 samples were collected and sent for Microbiology and Cytology.\n\nCryobiopsy: Transbronchial cryobiopsy was performed with a 1.1mm cryoprobe (freeze time 6 seconds).\nTotal 8 samples were collected and sent for Microbiology and Pathology.\nThis required substantially greater work (>40%) due to increased intensity and technical difficulty.\n\nFiducial: A fiducial marker loaded with bone wax was placed under fluoroscopy guidance prior to withdrawal.\n\nBrushing: Transbronchial brushing was performed with a protected cytology brush. 1 sample was collected for Cytology.\n\nLavage (BAL): Bronchial alveolar lavage was performed at the target site (20 cc instilled, 5 cc returned) and sent for Microbiology.\nAdditional lavage was performed at the subsegments of the RUL (40 cc instilled, 15 cc returned) and sent for Cell Count, Microbiology, and Cytology.\n\nROSE: Rapid On-Site Evaluation (ROSE) from the Ion procedure noted: Non-small cell lung carcinoma.\n\nEBUS Staging: The linear EBUS scope was introduced.\nAll lymph node stations were assessed; only those 5 mm or greater in short axis were considered for sampling.\nEndobronchial ultrasound elastography was used to assess stiffness (Type 1\u20133) to guide selection.\n\nStation 11L: < 10 mm on CT. Demonstrated Type 3 (stiff) elastographic pattern. Not sampled.\nStation 4L (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 7 (Subcarinal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 4R (Lower Paratracheal): < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\nStation 11Ri: < 10 mm on CT. Type 3 (stiff) pattern. Not sampled.\n\nNo biopsies were taken based upon ultrasound appearance.\n\nConclusion: Therapeutic aspiration was repeated to clean the airways of mucus and blood.\nThe patient tolerated the procedure well with no immediate complications.\nThe patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL transbronchial needle aspiration (4 samples) \u2014 Microbiology, Cytology \nRUL transbronchial cryobiopsies (8 samples) \u2014 Microbiology, Pathology \nRUL transbronchial brush (1 sample) \u2014 Cytology \nRUL subsegmental bronchoalveolar lavage \u2014 Microbiology \nRUL lobar bronchoalveolar lavage \u2014 Cell Count, Microbiology, Cytology \n\nIMPRESSION / PLAN\n58-year-old female with lung nodule.\nNodule successfully sampled via Ion robotic bronchoscopy; ROSE noted Non-small cell lung carcinoma.\nFiducial marker placed.\nEBUS staging performed; no lymph nodes required sampling.\n\nPlan:\nFollow up bronchoscopic lab work.\nFollow up CXR.\n"}
